Health Care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

MCK McKesson Corporation SEC Filings & Insider Trading Activity 2026

company
CIK 927653100 filings
S&P 500

MCK at a glance

McKesson Corporation (MCK, SEC CIK 927653) filed its latest 10-K annual report on May 8, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as November 6, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended March 31, 2026 (FY2026), McKesson Corporation (MCK) reported revenue of $403.4 billion (up 12.4% from FY2025) and net income of $4.8 billion. Diluted EPS was $38.38.
  • As of September 30, 2026, 59 institutional investment managers tracked by SignalX reported holding McKesson Corporation (MCK) shares worth $38.9 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Fraga Francisco on November 5, 2026 of 650 shares at $1102.96 per share.
  • In the last 90 days, MCK insiders reported 0 open-market purchases ($0) and 4 open-market sales ($2.2M) on Form 4, a net sale of $2.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$403.4B
+12.4% vs prior year
Insiders · 90 days
0 buys · 4 sells
Net −$2.2M
13F holders
59 funds
$38.9B · +1 vs prior quarter
Latest 8-K
Nov 4, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to 10-K risk factors during the quarter
  • Carried-forward risks remain unchanged, including regulatory, legal, operational, competitive, market, liquidity, debt, currency and concentration exposures

Management Discussion & Analysis

  • Revenue $110,957M, up 8% YoY from $103,150M, driven by pharmaceutical volumes and specialty pharmaceuticals
  • Gross margin 3.57% vs 3.43% YoY, operating-expense ratio 2.12% vs 2.07%
  • Best segment Oncology & Multispecialty: revenue $14,980M, up 24%; worst margin trend Medical-Surgical Solutions: 5.30% vs 7.47%
  • Operating cash flow $2,850M vs $1,502M; cash balance $6,619M vs $4,068M at March 31
  • Capital deployment: $3,400M repurchases and $198M dividends; regulatory uncertainty, drug pricing, and opioid liabilities remained headwinds

AI summary of the MCK 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 4, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Preliminary quarterly results for quarter ended September 30, 2026
  • Results available in Exhibit 99.1 for detailed financial metrics and management commentary

Item EX-99.1: Item EX-99.1

  • Q2 revenue $111.0B, up 8%, with adjusted EPS $11.68, up 18%, signaling strong operating momentum
  • Free cash flow $2.9B and $3.6B returned to shareholders year-to-date, including $3.4B in repurchases
Filed Oct 6, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Proposed acquisition of Option Care Health announced jointly by McKesson, CD&R and Option Care Health
  • Transaction details and strategic rationale contained in Exhibit 99.1 and the referenced company websites

Item EX-99.1: Item EX-99.1

  • McKesson investing approximately $1.4B for a 49% minority stake in Option Care Health, expanding specialty-care and home-infusion exposure
  • CD&R will control approximately 51%, with Option Care remaining separately managed and privately held after closing
Filed Aug 28, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Cybersecurity incident discovered August 25, 2026, affecting McKesson information systems
  • Investigation remains in early stages, creating ongoing uncertainty around scope and operational impact

AI summaries of MCK 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for MCK

Don't miss the next MCK filing

  • Alerts as it files. A push when MCK files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut MCK, by share count.
  • Ask anything. An AI agent that reads every MCK filing and answers with sources.

MCK alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Fraga FranciscoSellNov 5, 2026$1102.96
Fraga FranciscoSellNov 4, 2026$1050.00
Fraga FranciscoDNov 3, 2026-
Fraga FranciscoMNov 3, 2026-
Fraga FranciscoFNov 3, 2026$999.62
Fraga FranciscoSellOct 15, 2026$995.80
Rutledge Napoleon B JRSellSep 8, 2026$891.45
Lerman Bradley ESellAug 10, 2026$892.33

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$359.1B$403.4B
Gross Profit-$13.3B$14.6B
Operating Income-$4.4B$6.2B
Net Income-$3.3B$4.8B
Gross Margin-3.7%3.6%
Op. Margin-1.2%1.5%
Net Margin-0.9%1.2%
Balance Sheet
Total Assets$67.4B$75.1B$82.3B
Equity--$2.1B-$2.2B
ROE--158.9%-219.2%
Per Share
EPS-$25.72$38.38
Cash Flow
Operating CF-$6.1B$6.2B
CapEx$431.0M$537.0M$436.0M

Source: XBRL data in McKesson Corporation (MCK)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate MCK share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
MCK shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202659$38.88B
Q2 202658$38.21B
Q1 202659$44.80B
Q4 202556$40.00B
Q3 202555$41.74B
Q2 202553$38.29B
Q1 202552$26.32B
Q4 202445$17.85B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 437 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

MCK filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 6, 2026--
4Nov 5, 2026--
8-KNov 4, 2026Analysis-
10-QNov 4, 2026Analysis
4Oct 19, 2026--
8-KOct 6, 2026Analysis-
4Sep 10, 2026--
8-KAug 28, 2026Analysis-
4Aug 11, 2026--
4Aug 11, 2026--
10-QAug 5, 2026Analysis
8-KAug 5, 2026Analysis-
8-KJul 24, 2026Analysis-
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 23, 2026--
4Jul 8, 2026--
8-KJul 1, 2026Analysis-

Related Health Care companies

All Health Care →

MCK SEC filings: frequently asked questions

Are MCK insiders buying or selling?

In the last 90 days, McKesson Corporation (MCK) officers, directors and 10% owners reported no open-market purchases and 4 open-market sales worth $2.2 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold MCK stock?

As of September 30, 2026, the largest McKesson Corporation (MCK) holders among the 13F filers tracked by SignalX were BlackRock ($8.6 billion), Vanguard Capital Management LLC ($6.5 billion), State Street Corp ($4.7 billion), Morgan Stanley ($3.3 billion), Franklin Resources ($3.1 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was MCK's revenue in fiscal year 2026?

For the fiscal year ended March 31, 2026 (FY2026), McKesson Corporation (MCK) reported revenue of $403.4 billion (up 12.4% from FY2025) and net income of $4.8 billion. Diluted EPS was $38.38. The figures come from the XBRL data in the 10-K.

What did MCK report in its latest 8-K?

McKesson Corporation (MCK) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Preliminary quarterly results for quarter ended September 30, 2026.

What are the latest MCK SEC filings?

McKesson Corporation (MCK) filed its latest 10-K annual report on May 8, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on November 6, 2026.

What is MCK's SEC CIK number?

McKesson Corporation (MCK)'s SEC Central Index Key (CIK) is 927653. EDGAR lists every MCK filing under that number.

Ask anything about MCK

The research agent reads MCK's filings, financials, insider trades and 13F holders, then answers with sources.